Works matching IS 17574676 AND DT 2018 AND VI 10 AND IP 4

Results: 12

Retraction: “<italic>Haemophilus influenzae</italic> responds to glucocorticoids used in asthma therapy by modulation of biofilm formation and antibiotic resistance”.

Published in:: EMBO Molecular Medicine, 2018, v. 10, n. 4, p. 1, doi. 10.15252/emmm.201870001
Publication type:: Article

Sprouty2 loss‐induced IL6 drives castration‐resistant prostate cancer through scavenger receptor B1.

Published in:

EMBO Molecular Medicine, 2018, v. 10, n. 4, p. 1, doi. 10.15252/emmm.201708347

By:

Patel, Rachana;
Fleming, Janis;
Mui, Ernest;
Loveridge, Carolyn;
Repiscak, Peter;
Blomme, Arnaud;
Harle, Victoria;
Salji, Mark;
Ahmad, Imran;
Teo, Katy;
Hamdy, Freddie C.;
Hedley, Ann;
van den Broek, Niels;
Mackay, Gillian;
Edwards, Joanne;
Sansom, Owen J.;
Leung, Hing Y.

Publication type:

Article

Co‐targeting driver pathways in prostate cancer: two birds with one stone.

Published in:

EMBO Molecular Medicine, 2018, v. 10, n. 4, p. 1, doi. 10.15252/emmm.201808928

By:

Zoubeidi, Amina;
Gleave, Martin E.

Publication type:

Article

Role of NKp46<sup>+</sup> natural killer cells in house dust mite‐driven asthma.

Published in:

EMBO Molecular Medicine, 2018, v. 10, n. 4, p. 1, doi. 10.15252/emmm.201708657

By:

Haspeslagh, Eline;
van Helden, Mary J.;
Deswarte, Kim;
De Prijck, Sofie;
van Moorleghem, Justine;
Boon, Louis;
Hammad, Hamida;
Vivier, Eric;
Lambrecht, Bart N.

Publication type:

Article

Trio sequencing in pediatric cancer and clinical implications.

Published in:

EMBO Molecular Medicine, 2018, v. 10, n. 4, p. 1, doi. 10.15252/emmm.201708641

By:

Kuhlen, Michaela;
Borkhardt, Arndt

Publication type:

Article

An allosteric inhibitor of <italic>Mycobacterium tuberculosis</italic> ArgJ: Implications to a novel combinatorial therapy.

Published in:

EMBO Molecular Medicine, 2018, v. 10, n. 4, p. 1, doi. 10.15252/emmm.201708038

By:

Mishra, Archita;
Mamidi, Ashalatha S.;
Rajmani, Raju S.;
Ray, Ananya;
Roy, Rajanya;
Surolia, Avadhesha

Publication type:

Article

Dual inhibition of AKT‐mTOR and AR signaling by targeting HDAC3 in <italic>PTEN</italic>‐ or <italic>SPOP</italic>‐mutated prostate cancer.

Published in:

EMBO Molecular Medicine, 2018, v. 10, n. 4, p. 1, doi. 10.15252/emmm.201708478

By:

Yan, Yuqian;
An, Jian;
Yang, Yinhui;
Wu, Di;
Bai, Yang;
Cao, William;
Ma, Linlin;
Chen, Junhui;
Yu, Zhendong;
He, Yundong;
Jin, Xin;
Pan, Yunqian;
Ma, Tao;
Wang, Shangqian;
Hou, Xiaonan;
Weroha, Saravut John;
Karnes, R. Jeffrey;
Zhang, Jun;
Westendorf, Jennifer J.;
Wang, Liguo

Publication type:

Article

Tranilast directly targets NLRP3 to treat inflammasome‐driven diseases.

Published in:

EMBO Molecular Medicine, 2018, v. 10, n. 4, p. 1, doi. 10.15252/emmm.201708689

By:

Huang, Yi;
Jiang, Hua;
Chen, Yun;
Wang, Xiaqiong;
Yang, Yanqing;
Tao, Jinhui;
Deng, Xianming;
Liang, Gaolin;
Zhang, Huafeng;
Jiang, Wei;
Zhou, Rongbin

Publication type:

Article

Counteracting the effects of TNF receptor‐1 has therapeutic potential in Alzheimer's disease.

Published in:

EMBO Molecular Medicine, 2018, v. 10, n. 4, p. 1, doi. 10.15252/emmm.201708300

By:

Steeland, Sophie;
Gorlé, Nina;
Vandendriessche, Charysse;
Balusu, Sriram;
Brkic, Marjana;
Van Cauwenberghe, Caroline;
Van Imschoot, Griet;
Van Wonterghem, Elien;
De Rycke, Riet;
Kremer, Anneke;
Lippens, Saskia;
Stopa, Edward;
Johanson, Conrad E.;
Libert, Claude;
Vandenbroucke, Roosmarijn E.

Publication type:

Article

An FGFR3/MYC positive feedback loop provides new opportunities for targeted therapies in bladder cancers.

Published in:

EMBO Molecular Medicine, 2018, v. 10, n. 4, p. 1, doi. 10.15252/emmm.201708163

By:

Mahe, Mélanie;
Dufour, Florent;
Neyret‐Kahn, Hélène;
Moreno‐Vega, Aura;
Beraud, Claire;
Shi, Mingjun;
Hamaidi, Imene;
Sanchez‐Quiles, Virginia;
Krucker, Clementine;
Dorland‐Galliot, Marion;
Chapeaublanc, Elodie;
Nicolle, Remy;
Lang, Hervé;
Pouponnot, Celio;
Massfelder, Thierry;
Radvanyi, François;
Bernard‐Pierrot, Isabelle

Publication type:

Article

Human ALPI deficiency causes inflammatory bowel disease and highlights a key mechanism of gut homeostasis.

Published in:

EMBO Molecular Medicine, 2018, v. 10, n. 4, p. 1, doi. 10.15252/emmm.201708483

By:

Parlato, Marianna;
Charbit‐Henrion, Fabienne;
Pan, Jie;
Romano, Claudio;
Duclaux‐Loras, Rémi;
Le Du, Marie‐Helene;
Warner, Neil;
Francalanci, Paola;
Bruneau, Julie;
Bras, Marc;
Zarhrate, Mohammed;
Bègue, Bernadette;
Guegan, Nicolas;
Rakotobe, Sabine;
Kapel, Nathalie;
De Angelis, Paola;
Griffiths, Anne M.;
Fiedler, Karoline;
Crowley, Eileen;
Ruemmele, Frank

Publication type:

Article

Inhibition of DDR1‐BCR signalling by nilotinib as a new therapeutic strategy for metastatic colorectal cancer.

Published in:

EMBO Molecular Medicine, 2018, v. 10, n. 4, p. 1, doi. 10.15252/emmm.201707918

By:

Jeitany, Maya;
Leroy, Cédric;
Tosti, Priscillia;
Lafitte, Marie;
Le Guet, Jordy;
Simon, Valérie;
Bonenfant, Debora;
Robert, Bruno;
Grillet, Fanny;
Mollevi, Caroline;
El Messaoudi, Safia;
Otandault, Amaëlle;
Canterel‐Thouennon, Lucile;
Busson, Muriel;
Thierry, Alain R.;
Martineau, Pierre;
Pannequin, Julie;
Roche, Serge;
Sirvent, Audrey

Publication type:

Article